Last reviewed 2026-04-20 · How we verify

Topical adrenaline

At a glance

Approved indications

No approved indications tracked.

Common side effects

• Nasopharyngitis
• Headache
• Pyrexia
• Folliculitis
• Oral herpes
• Conjunctivitis allergic
• Dry eye
• Diarrhoea
• Back pain
• Cellulitis
• Furuncle
• Alanine aminotransferase increased

Key clinical trials

• Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials (PHASE2, PHASE3)
• Clinical Outcomes of Mandibular Primary Molar Extraction Using Physics Forceps in Children (NA)
• Pain Experience Using Lidocaine Adrenaline Tetracaine (LAT) Gel Versus Lidocaine Infiltration for Laceration Repair in Adults (PHASE4)
• This Clinical Trial Aims to Compare the Effectiveness of Two Intra-pulpal Cryotherapy Techniques-Endo-ice and Ice Sticks-in Decreasing Intra-operative Pain and Enhancing the Success of Local Anesthesia During Pulpectomy of Mandibular Molars With Symptomatic Irreversible Pulpitis. (NA)
• The Use of Lidocaine Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision (PHASE4)
• Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis (PHASE4)
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor (PHASE3)
• Parasitic Ulcer Treatment Trial (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Topical adrenaline CI brief — competitive landscape report
• Topical adrenaline updates RSS · CI watch RSS
• Cairo University portfolio CI